首页> 美国卫生研究院文献>Case Reports in Gastroenterology >Transplant-Amenable Hepatocellular Carcinoma in a Fontan Patient
【2h】

Transplant-Amenable Hepatocellular Carcinoma in a Fontan Patient

机译:丰坦患者的移植适应性肝细胞癌

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The Fontan circulation alters a patient's physiology and imparts long-term risks related to chronically elevated systemic venous pressure. An increasing number of patients with Fontan physiology are surviving into adulthood and are at risk of hepatic sequalae. The ideal timeline and method of hepatic surveillance in the Fontan population remains to be defined. In this case, the patient was diagnosed with hepatocellular carcinoma more than 20 years after undergoing the Fontan procedure and was a candidate for combined heart-liver transplant. That her disease progressed prior to organ availability supports the argument for hepatic surveillance in this population.
机译:丰坦循环会改变患者的生理状况,并带来与长期升高的系统静脉压有关的长期风险。越来越多的具有Fontan生理学的患者能够生存到成年并有患肝性角膜溃疡的风险。丰坦人群中理想的肝监测时间表和方法仍有待确定。在这种情况下,患者接受了Fontan手术后被诊断出肝细胞癌超过20年,并且是心脏-肝联合移植的候选对象。她的疾病在器官可利用之前就已经发展,这支持了该人群进行肝监视的观点。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号